US3981865A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bis-type penicillins and process for producing the same
Assignee: Toyama Chemical Co Ltd
•
Filing: 1975-06-11
•
Granted: 1976-09-21
•
Expires: 1995-06-11
Abstract
Abstract Novel bis-type penicillins containing a (thio)acylureido group in the molecule, which are valuable antibacterial compounds for use in mammals including a human being.
Inventors
- 👤 Isamu Saikawa
- 👤 Shuntaro Takano
- 👤 Okuta Takashima
- 👤 Kaishu Momonoi
- 👤 Seietsu Kuroda
- 👤 Miwako Komatsu
- 👤 Takashi Yasuda
- 👤 Kyoko Kasuya
- 👤 Yutaka Kodama
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 04:41
CPC Classifications
C; C07; C07D; C07D499/00
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
115 words
A compound represented by the general formula (I), ##EQU13## wherein R is the radical derived from a conventional penicillin acylamido group represented by the formula ##EQU14## in which R 4 represents a substituted or unsubstituted alkyl, cycloalkyl, cycloalkenyl, cycloalkadienyl, aryl, aralkyl, aryloxy, alkylthioalkyl, or a heterocyclic group; and R 5 represents a hydrogen atom; R 4 and R 5 together with the common carbon atom may form a cycloalkyl, cycloalkenyl or cycloalkadienyl ring; R 1 represents a hydrogen atom, a conventional penicillin blocking group or a conventional penicillin saltforming cation R 2 represents a substituted or unsubstituted alkylene, alkenylene, cycloalkylene, arylene, alkylenediaryl group; X and Y are individually an oxygen atom or a sulfur atom.
Claim 2
Dependent Claim
115 words
A compound represented by the general formula (I), ##EQU13## wherein R is the radical derived from a conventional penicillin acylamido group represented by the formula ##EQU14## in which R 4 represents a substituted or unsubstituted alkyl, cycloalkyl, cycloalkenyl, cycloalkadienyl, aryl, aralkyl, aryloxy, alkylthioalkyl, or a heterocyclic group; and R 5 represents a hydrogen atom; R 4 and R 5 together with the common carbon atom may form a cycloalkyl, cycloalkenyl or cycloalkadienyl ring; R 1 represents a hydrogen atom, a conventional penicillin blocking group or a conventional penicillin saltforming cation R 2 represents a substituted or unsubstituted alkylene, alkenylene, cycloalkylene, arylene, alkylenediaryl group; X and Y are individually an oxygen atom or a sulfur atom.
Claim 3
Dependent Claim
40 words
A compound represented by the general formula (Ia), ##EQU15## wherein R 1 , Y and R 4 and R 5 are defined in claim 1 and R 6 represents a substituted or unsubstituted alkylene, alkenylene, cycloalkylene, arylene or alkylenediaryl group.
Claim 4
Dependent Claim
19 words
A compound according to claim 2, wherein R 6 is a substituted or unsubstituted alkylene, alkenylene or cycloalkylene group.
Claim 5
Dependent Claim
16 words
A compound according to claim 2, wherein R 6 is a substituted or unsubstituted arylene group.
Claim 6
Dependent Claim
13 words
A compound according to claim 2, wherein R 6 is an alkylenediaryl group.
Claim 7
Dependent Claim
13 words
A compound according to claim 1, wherein R 1 is a hydrogen atom.
Claim 8
Dependent Claim
47 words
A compound according to claim 1, wherein R 1 is selected from the group consisting of ester-forming groups capable of being removed by catalytic reduction, chemical reduction or hydrolysis under mild conditions and ester-forming groups capable of being easily removed owing to enzymes in a living body.
Claim 9
Dependent Claim
63 words
A compound selected from the group consisting of N,n'-1-methyl-1-propylmalonyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-succinyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-glutaryl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-adipoly-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-pimeloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-sebacoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-dodecanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-tridecanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-fumaroyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-1,4-cyclohexanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-sebacoyl-bis[6-(D(-)-α-ureido-hydroxyphenylacetamido penicillanic acid], N,n'-sebacoyl-bis[6-(1-ureidocyclohexylcarbonylamido) penicillanic acid], N,n'-terephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-isophthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-terephthaloyl-bis[6-(D(-)-α-thioureidophenylacetamido) penicillanic acid], N,n'-2-nitroterephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-2,5-dimethoxyterephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], and N,n'-2,6-naphthalenedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid].
Claim 10
Dependent Claim
63 words
A compound selected from the group consisting of N,n'-1-methyl-1-propylmalonyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-succinyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-glutaryl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-adipoly-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-pimeloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-sebacoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-dodecanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-tridecanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-fumaroyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-1,4-cyclohexanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-sebacoyl-bis[6-(D(-)-α-ureido-hydroxyphenylacetamido penicillanic acid], N,n'-sebacoyl-bis[6-(1-ureidocyclohexylcarbonylamido) penicillanic acid], N,n'-terephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-isophthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-terephthaloyl-bis[6-(D(-)-α-thioureidophenylacetamido) penicillanic acid], N,n'-2-nitroterephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-2,5-dimethoxyterephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], and N,n'-2,6-naphthalenedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid].
Claim 11
Dependent Claim
5 words
The compound N,n'-4,4'-ethylenedibenzoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid].
Claim 12
Dependent Claim
5 words
The compound N,n'-4,4'-ethylenedibenzoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid].
Claim 13
Dependent Claim
15 words
A compound selected from the group consisting of dipivaloyloxymethyl N,N'-terephthaloyl-bis-[6-(D(-)-α-ureidophenylacetamido) penicillanate], and diphthalidyl N,N'-sebacoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanate].
Claim 14
Dependent Claim
15 words
A compound selected from the group consisting of dipivaloyloxymethyl N,N'-terephthaloyl-bis-[6-(D(-)-α-ureidophenylacetamido) penicillanate], and diphthalidyl N,N'-sebacoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanate].
Claim 15
Dependent Claim
18 words
A compound according to claim 1, wherein R 1 is a cation capable of forming a non-toxic salt.
Claim 16
Dependent Claim
10 words
A non-toxic salt of a compound according to claim 8.
Claim 17
Dependent Claim
7 words
N,N'-succinyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid] or its non-toxic salt.
Claim 18
Dependent Claim
7 words
N,N'-succinyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid] or its non-toxic salt.
Claim 19
Dependent Claim
12 words
A pharmaceutical composition containing an active ingredient a compound of claim 1.
References Cited (Backward Citations)
US3838152A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1979-09-21 | 1980-03-22 | 1980-09-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1983-09-21 | 1984-03-22 | 1984-09-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1987-09-21 | 1988-03-22 | 1988-09-21 | $7700.00 | Window Closed / Lapsed |